33 results on '"Semina, Svetlana E."'
Search Results
2. Selective pressure of endocrine therapy activates the integrated stress response through NFκB signaling in a subpopulation of ER positive breast cancer cells
3. Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors
4. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells
5. ASCT2 is the primary serine transporter in cancer cells
6. Supplemental Table 3 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
7. Supplemental Table 2 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
8. Supplementary Figures 1-6 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
9. Supplemental Materials and Methods and Figure Legends from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
10. Data from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
11. Supplemental Table 1 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
12. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack
13. Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors
14. Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells
15. Abstract P5-11-01: Identification of novel ER and ER-NFκB driven stem-like cell populations in ER+ breast cancer
16. Additional file 4 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
17. Additional file 2 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
18. Additional file 3 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
19. Additional file 1 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
20. Additional file 7 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
21. Additional file 6 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
22. Additional file 5 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
23. Additional file 8 of Selective pressure of endocrine therapy activates the integrated stress response through NF��B signaling in a subpopulation of ER positive breast cancer cells
24. Abstract PS16-04: Estrogen receptor (ER) and NFkB activity determines cancer stem cell properties in ER positive breast cancer
25. Update on the Role of NFκB in Promoting Aggressive Phenotypes of Estrogen Receptor–Positive Breast Cancer
26. The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
27. Correction: Corrigendum: Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol
28. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
29. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol
30. Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs.
31. Corrigendum: Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol.
32. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol.
33. ASCT2 is the primary serine transporter in cancer cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.